Company Update ASTRAZENECA PHARMA INDIA LTD. - 506820 - Statement Of Investor Complaints For The Quarter Ended December 2020 BSE India No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1120 Name of the Signatory :- PRATAP RUDRADesignation :- Company Secretary and Compliance Officer